Vimarsana
Biggest News Aggregation in the World

Positive Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Positive Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Positive Phase Today - Breaking & Trending Today

Meaningful Improvement in Overall Survival (OS) and Tolerability Observed in Patients Receiving Trilaciclib in Combination with a TROP2 Antibody-Drug Conjugate (ADC) - Vimarsana News

Meaningful Improvement in Overall Survival (OS) and Tolerability Observed in Patients Receiving Trilaciclib in Combination with a TROP2 Antibody-Drug Conjugate (ADC)

- New Positive Phase 2 Results in Metastatic Triple Negative Breast Cancer Indicate That Use of Trilaciclib in Combination with a TROP2 ADC May Be Associated with Improved Median OS Compared to...

Meaningful Improvement in Overall Survival (OS) and Tolerability Observed in Patients Receiving Trilaciclib in Combination with a TROP2 Antibody-Drug Conjugate (ADC) - G1 Therapeutics (NASDAQ:GTHX) - Vimarsana News

Meaningful Improvement in Overall Survival (OS) and Tolerability Observed in Patients Receiving Trilaciclib in Combination with a TROP2 Antibody-Drug Conjugate (ADC) - G1 Therapeutics (NASDAQ:GTHX)

- New Positive Phase 2 Results in Metastatic Triple Negative Breast Cancer (mTNBC) Indicate That Use of Trilaciclib in Combination with a TROP2 ADC May Be Associated with Improved Median OS Compared to Historical Data

Milestone Pharmaceuticals : Corporate Presentation -March 28, 2024 at 08:38 am EDT - Vimarsana News

Milestone Pharmaceuticals : Corporate Presentation -March 28, 2024 at 08:38 am EDT

Company Overview March 28, 2024 Forward Looking Statement The Presentation contains forward-looking statements within...

Psychiatry in the News: January 2024 - Vimarsana News

Psychiatry in the News: January 2024

Here are some updates from the world of psychiatry throughout the month of January.

Alnylam Highlights Significant Progress with Platform Innovation and Clinical Pipeline at R&D Day - Vimarsana News

Alnylam Highlights Significant Progress with Platform Innovation and Clinical Pipeline at R&D Day

– Company Anticipates Investigational New Drug Applications for Nine or More Programs with Targets Expressed in the Liver, Central Nervous System, Adipose Tissue, and Muscle by End of 2025...